The present invention relates to stable pharmaceutical composition of fesoterodine or pharmaceutically acceptable salts or solvates thereof and the process for preparing the same. Further the present invention relates to stable pharmaceutical composition comprising fesoterodine a stabilizer and at least one release controlling agent.